3/ KEYNOTE-564 is a phase 3, double-blind, randomized, placebo-controlled trial
- ccRCC
- ECOG PS 0-1
- ≤12 weeks following surgery
- Intermediate-high, high risk M0, or M1 NED (w/in 1 year of nephrectomy)

Pelvic lymph node dissection in #ProstateCancer : Update of the limited vs. extended randomized clinical trial. Presented by Karim Touijer Memorial Sloan Kettering Cancer Center. #EAU24 written coverage by @rksayyid, MD, MSc University of Toronto > bit.ly/3VM5qCk European Association of Urology (EAU)

Satisfying data to keep extended LND by Karim Touijer #EAU24 European Association of Urology (EAU) ..

Prof Freddy Hamdy provides incisive discussion re PLND for #prostatecancer including possible explanations of the findings, and implications for future practice & research
#EAU24

Congrats Sigrid Carlsson on the European Urology Platinum Award 🎉🎉

Game changing session #EAU24 sees Karim Touijer certainly shake up the status quo!

Updated results from Memorial Sloan Kettering Cancer Center #clinicaltrial shows ePLND did not change BCR but reduces 2ry outcome metastases: esp distant, esp if pN+

Great debate about the value of Pelvic lymph node dissection in #prostatecancer at the #EAU24 Declan Murphy alberto briganti

Don’t miss !!!
Game changing session 'Lymph node dissection in prostate cancer: Is the book closed?' Will discuss latest results of node dissection randomized trial with Pr Freddie Hamdy

Tomorrow sunday 10 am
e auditorium. #EAU24 UrologyMSK #prostatecancer

UroToday.com Amanda Myers Succinct slide summary of tremendous effort by
Amanda Myers MD Anderson Cancer Center #OncSurgery
European Urology Oncology
Open Access link: authors.elsevier.com/a/1i6Q09Cfv-xp……

Alberto Briganti B.C. Leibovich MD Marco Moschini
Morgan Roupret Shahrokh F. Shariat Philippe spiess @Astenzl
@Tanejauro Karim Touijer

Back again on Rising Stars 14 edition !

Congratulations to all participants and faculty. Outstanding opportunity for the upcoming class of Urologists. Good wind in their sails.

Congratulations Carlos Toribio Vazquez … new #risingstar 2024!! Extraordinary performance of all attendees. Thank you IpsenUS AEU Antonio Alcaraz

Wonderful initiative, thank you to all. Steps forward for #Morocco

Our collaborative review on LND in GU cancers; tremendous effort by Amanda Myers MD Anderson Cancer Center #OncSurgery European Urology Oncology

Open Access link: authors.elsevier.com/a/1i6Q09Cfv-xp…

Alberto Briganti B.C. Leibovich MD #SethLerner Marco Moschini Morgan Roupret Shahrokh F. Shariat Philippe spiess @Astenzl

Joan Palou Redorta Prostate: PLND templates lack consensus; terminology not uniform.
Risk stratification key and nomograms now incorporate PSMA Giorgio Gandaglia Alberto Briganti
Ongoing de-escalation trials awaited.
- PLND vs no PLND trials: PREDICT Martini-Klinik am UKE & Karim Touijer UrologyMSK
- PSMA

Peace!!!!

m.youtube.com/watch?v=myVi6p…

m.youtube.com/watch?v=XqvKDC…

Agradecido a toda la comunidad urologica americana por la medalla Shlomo Raz, la mas alta condecoración de la CAU. Orgulloso de ser uno mas de vosotros. Orgulloso de ser Latino

Immensely grateful for your compassion, wishes and concerns.
If you wish to help #Morocco #moroccoearthquake #Morocco EarthquakeRelief
Thank you for your generosity

Management of GG1 recurrent prostate cancer after radiation or ablative therapy.
Hope this data help.

urldefense.com/v3/__https://a…

What a terrific group! Many thanks to everyone who support us in our mission and grateful to our patients for the trust they put in us.